Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
In 2010 the incidence of neo-natal Group B Streptococcus (GBS) disease in South Africa was 3 per 1000 live births, more than twice the global average of 1.21 per 1000 live births. A recent life cycle impact assessment showed that a new vaccine against GBS disease in South Africa could have a potenti...
| Main Author: | |
|---|---|
| Other Authors: | |
| Format: | Thesis |
| Language: | English |
| Published: |
Centre for Bioprocess Engineering Research
2021
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|